Sign Up
Stories
FDA Warning: Cardinal's Syringe Issues
Share
4P-Pharma Secures €15 Million Funding
ABBio Innovates Antibody Development
ABIONYX Pharma Files 2023 Document
Acquisition Progress Amid Safety Concern
Afya Limited Expands Medical Seats in Br...
Avid Bioservices Financial Turmoil
Overview
API
Cardinal Health receives FDA warning for unapproved syringes, citing safety concerns and violations during inspection at their facility, prompting corrective actions.
Ask a question
How does this incident reflect broader challenges in ensuring the safety and compliance of medical devices sourced globally?
How might this FDA warning impact Cardinal Health's reputation and market position?
What measures can Cardinal Health implement to prevent similar regulatory issues in the future?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Feb 2024
Mar 2024
Apr 2024
Coverage